Abstract PS7-19: Pre/perimenopausal (preMeno) women receiving palbociclib (PAL) for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) in a real-world setting: Treatment patterns from POLARIS

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Real World Setting ◽

Real-World Treatment Patterns Of Everolimus + Exemestane In Patients With Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Advanced Breast Cancer By Line Of Therapy: A Global Chart Review

Value in Health ◽

10.1016/j.jval.2016.03.1639 ◽

2016 ◽

Vol 19 (3) ◽

pp. A136

Author(s):

V Costanzo ◽

J Zarbá ◽

A Michelotti ◽

L Livi ◽

C Villanueva ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Chart Review ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Epidermal Growth ◽

Line Of Therapy

309P Real-world effectiveness of alpelisib (ALP) + fulvestrant (FUL) compared with standard treatment among patients (Pts) with hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2–) PIK3CA-mutated (Mut) advanced breast cancer (ABC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.411 ◽

2020 ◽

Vol 31 ◽

pp. S366

Author(s):

S. Turner ◽

S.K.L. Chia ◽

H. Kanakamedala ◽

W-C. Hsu ◽

J. Park ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Hormone Receptor ◽

Standard Treatment ◽

Growth Factor Receptor ◽

Abstract PD10-03: Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings

10.1158/1538-7445.sabcs19-pd10-03 ◽

2020 ◽

Author(s):

Gabrielle Rocque ◽

Joanne L Blum ◽

Aldemar Montero ◽

Ibrahim Nakhoul ◽

Sobha Kurian ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Growth Factor Receptor ◽

Rationale and design of the real-world Hellenic disease management patterns with everolimus for women with hormone-receptor-positive, human epidermal growth factor ReceptOR-2 negative advanced breast cancer (The MIRROR) study

The Breast ◽

10.1016/s0960-9776(17)30234-5 ◽

2017 ◽

Vol 32 ◽

pp. S69

Author(s):

C. Karanikiotis ◽

G. Kesisis ◽

I. Xanthakis ◽

A. Alexopoulos ◽

V. Barbounis ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Disease Management ◽

Real World ◽

Hormone Receptor ◽

Growth Factor Receptor ◽

Real-World Treatment Patterns for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Europe and the United States

Oncology and Therapy ◽

10.1007/s40487-016-0033-z ◽

2016 ◽

Vol 4 (2) ◽

pp. 189-197 ◽

Cited By ~ 9

Author(s):

Rita Caldeira ◽

Mark Scazafave

Keyword(s):

Breast Cancer ◽

United States ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

The United States ◽

Treatment Patterns ◽

318P The real-world Hellenic disease management patterns with everolimus (EVE) for women with hormone-receptor-positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer (aBC): ‘The MIRROR’ study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.420 ◽

2020 ◽

Vol 31 ◽

pp. S370

Author(s):

F. Zagouri

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Disease Management ◽

Real World ◽

Hormone Receptor ◽

Growth Factor Receptor ◽

315P Treatment patterns in black and indigenous people and people of color (BIPOC) receiving palbociclib for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in a real-world setting: POLARIS study results

Annals of Oncology ◽

10.1016/j.annonc.2021.08.598 ◽

2021 ◽

Vol 32 ◽

pp. S502

Author(s):

G. Rocque ◽

J. Blum ◽

A. Montero ◽

S. Sonnier ◽

S. McCune ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

People Of Color ◽

Real World Setting ◽

Study Results ◽

Abstract P1-13-08: Real-world treatment durations without chemotherapy (CT) for hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (mBC)

10.1158/1538-7445.sabcs14-p1-13-08 ◽

2015 ◽

Author(s):

Elyse Swallow ◽

Jenny Wang ◽

Darren Thomason ◽

Ruo-Ding Tan ◽

Andrew Kageleiry ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

PCN361 POOR PROGNOSTIC FACTORS AND THEIR IMPACT ON TREATMENT PATTERNS AND OUTCOMES FOR WOMEN WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC) IN CANADA

Value in Health ◽

10.1016/j.jval.2020.04.1816 ◽

2020 ◽

Vol 23 ◽

pp. S88

Author(s):

A. Rider ◽

A. Bailey ◽

K. Lewis ◽

N. Ashki ◽

C. Lenhu ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Epidermal Growth ◽

Impact On Treatment

Abstract P3-06-09: Survival among patients with hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer: A real-world observational study

10.1158/0008-5472.sabcs13-p3-06-09 ◽

2013 ◽

Cited By ~ 1

Author(s):

NM Engel-Nitz ◽

Y Hao ◽

G Gomez Rey ◽

J Sullivan ◽

J Willemann Rogerio

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Observational Study ◽

Real World ◽

Hormone Receptor ◽

Growth Factor Receptor ◽